- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04817683
Study on the Relationship Between Mobile Phone Addiction and Functional Gastrointestinal Disorders
March 23, 2021 updated by: Second Affiliated Hospital of Xi'an Jiaotong University
Exploration of the Relationship Between Mobile Phone Addiction and Functional Gastrointestinal Disorders, a Cross-sectional Study
A cross-sectional study was conducted to collect the relevant data of college students' mobile phone addiction and FGIDs (IBS, FD) in the form of questionnaire, so as to understand the situation of college students' mobile phone addiction and the incidence of FGIDs (IBS and FD), and explore the correlation, so as to provide new ideas and scientific basis for the prevention, diagnosis and treatment of FGIDs among college students.
Study Overview
Status
Completed
Conditions
Detailed Description
This study adopts the method of cross-sectional survey to collect the relevant data of Chinese college students' mobile phone addiction and FGIDs (IBS, FD) in the form of online and face-to-face questionnaire, so as to understand the situation of Chinese college students' mobile phone addiction and the incidence of FGIDs (IBS, FD), and explore the correlation, so as to provide new ideas and scientific basis for the prevention, diagnosis and treatment of FGIDs.
Study Type
Observational
Enrollment (Actual)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710004
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
College students over the age of 17 across the country
Description
Inclusion Criteria:
- College students from all over the country, over 17 years old, have a physical examination before entering school
- Sign the informed consent form, voluntarily participate and fill in the questionnaire
Exclusion Criteria:
- People with diabetes, hyperthyroidism or hypothyroidism, peptic ulcer, inflammatory bowel disease, digestive tract tumor or severe medical and surgical disease
- History of abdominal surgery (such as esophagus, stomach, small intestine, colon, rectum, appendix, gallbladder, hysterectomy, cesarean section)
- Recently, there are some alarm symptoms, such as relieving black stool, bloody stool, hematemesis, abnormal anemia, fever, abnormal weight loss (no intention to lose weight, weight loss 5 kg in 3 months), change of defecation habits, dysphagia and so on
- In the past 4 weeks, he has taken drugs that affect the judgment of gastrointestinal symptoms, such as anti-inflammatory painkillers, diazepam drugs, anti-anxiety drugs, depressants and so on
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of irritable bowel syndrome among College Students.Risk factors of irritable bowel syndrome.
Time Frame: 2020.07.03-2020.12.28
|
The irritable bowel syndrome was diagnosed by the Rome IV diagnostic questionnaire, and then the incidence of irritable bowel syndrome was calculated by SPSS.
Through PHQ-9 questionnaire to diagnose depression, GAD-7 questionnaire to diagnose anxiety, MPAI questionnaire to diagnose mobile phone addiction, AIS questionnaire to diagnose insomnia, logistic regression analysis to calculate OR value and P value, to understand the relationship between irritable bowel syndrome and anxiety, depression, insomnia, mobile phone addiction.
|
2020.07.03-2020.12.28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of functional dyspepsia among College Students.Risk factors of functional dyspepsia.
Time Frame: 2020.07.03-2020.12.28
|
The functional dyspepsia was diagnosed by the Rome IV diagnostic questionnaire, and then the incidence of functional dyspepsia was calculated by SPSS.
Through PHQ-9 questionnaire to diagnose depression, GAD-7 questionnaire to diagnose anxiety, MPAI questionnaire to diagnose mobile phone addiction, AIS questionnaire to diagnose insomnia, logistic regression analysis to calculate OR value and P value, to understand the relationship between functional dyspepsia and anxiety, depression, insomnia, mobile phone addiction.
|
2020.07.03-2020.12.28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: jinhai Wang, MD, Second Affilated Hospital of Xi'an Jiaotong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Actual)
December 28, 2020
Study Completion (Actual)
December 28, 2020
Study Registration Dates
First Submitted
July 3, 2020
First Submitted That Met QC Criteria
March 23, 2021
First Posted (Actual)
March 26, 2021
Study Record Updates
Last Update Posted (Actual)
March 26, 2021
Last Update Submitted That Met QC Criteria
March 23, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IBS - Irritable Bowel Syndrome
-
Guy BoeckxstaensFund for Scientific Research, Flanders, BelgiumRecruiting
-
Kyle Staller, MD, MPHArdelyxRecruitingIBS - Irritable Bowel Syndrome | IBSUnited States
-
University of California, Los AngelesRecruitingIBS - Irritable Bowel SyndromeUnited States
-
AstraZenecaCompletedIrritable Bowel Syndrome-IBSChina
-
Arizona State UniversityCompletedIBS - Irritable Bowel SyndromeUnited States
-
Xiyuan Hospital of China Academy of Chinese Medical...UnknownIBS (Irritable Bowel Syndrome)China
-
Seton Healthcare FamilyWithdrawnIrritable Bowel Syndrome (IBS)United States
-
Glycom, Inc.University of North CarolinaCompletedIrritable Bowel Syndrome (IBS)United States
-
GlaxoSmithKlineCompletedIrritable Bowel Syndrome (IBS)United States
-
The Royal Wolverhampton Hospitals NHS TrustRecruiting